Zimmerman TJ - Search Results

1

Topical ophthalmic beta blockers: a comparative review.

Zimmerman TJ. Zimmerman TJ. J Ocul Pharmacol. 1993 Winter;9(4):373-84. doi: 10.1089/jop.1993.9.373. J Ocul Pharmacol. 1993. PMID: 7906296 Review.

2

The impact of ocular adverse effects in patients treated with topical prostaglandin analogs: changes in prescription patterns and patient persistence.

Zimmerman TJ, Hahn SR, Gelb L, Tan H, Kim EE. Zimmerman TJ, et al. J Ocul Pharmacol Ther. 2009 Apr;25(2):145-52. doi: 10.1089/jop.2008.0072. J Ocul Pharmacol Ther. 2009. PMID: 19284321

3

Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.

Olander K, Zimmerman TJ, Downes N, Schoenfelder J; Xalacom/Latanoprost Study Group. Olander K, et al. Among authors: zimmerman tj. Clin Ther. 2004 Oct;26(10):1619-29. doi: 10.1016/j.clinthera.2004.10.009. Clin Ther. 2004. PMID: 15598478 Clinical Trial.

4

Changing paradigms in the medical treatment of glaucoma.

Soltau JB, Zimmerman TJ. Soltau JB, et al. Among authors: zimmerman tj. Surv Ophthalmol. 2002 Aug;47 Suppl 1:S2-5. doi: 10.1016/s0039-6257(02)00291-6. Surv Ophthalmol. 2002. PMID: 12204696 Review.

5

Intraocular pressure, safety, and quality of life in glaucoma patients switching to latanoprost from monotherapy treatments.

Zimmerman TJ, Stewart WC; Latanoprost Axis Study Group. Zimmerman TJ, et al. J Ocul Pharmacol Ther. 2003 Oct;19(5):405-15. doi: 10.1089/108076803322472971. J Ocul Pharmacol Ther. 2003. PMID: 14583133 Clinical Trial.

6

Timolol hemihydrate vs timolol maleate to treat ocular hypertension and open-angle glaucoma.

DuBiner HB, Hill R, Kaufman H, Keates EU, Zimmerman TJ, Mandell AI, Mundorf TK, Bahr RL, Schwartz LW, Towey AW, Hurvitz LM, Starita RJ, Sassani JW, Ropo A, Gunn R, Stewart WC. DuBiner HB, et al. Among authors: zimmerman tj. Am J Ophthalmol. 1996 May;121(5):522-8. doi: 10.1016/s0002-9394(14)75426-1. Am J Ophthalmol. 1996. PMID: 8610795 Clinical Trial.

7

Therapeutic index of pilocarpine, carbachol, and timolol with nasolacrimal occlusion.

Zimmerman TJ, Sharir M, Nardin GF, Fuqua M. Zimmerman TJ, et al. Am J Ophthalmol. 1992 Jul 15;114(1):1-7. doi: 10.1016/s0002-9394(14)77404-5. Am J Ophthalmol. 1992. PMID: 1621773 Clinical Trial.

8

Carbachol dose response.

Zimmerman TJ, Dukar U, Nardin GF, Patchett R, Fuqua M. Zimmerman TJ, et al. Am J Ophthalmol. 1989 Oct 15;108(4):456-7. doi: 10.1016/s0002-9394(14)73323-9. Am J Ophthalmol. 1989. PMID: 2801872 No abstract available.

9

Automated perimetry, tonometry, and questionnaire in glaucoma screening.

Mundorf TK, Zimmerman TJ, Nardin GF, Kendall KS. Mundorf TK, et al. Among authors: zimmerman tj. Am J Ophthalmol. 1989 Nov 15;108(5):505-8. doi: 10.1016/0002-9394(89)90425-x. Am J Ophthalmol. 1989. PMID: 2683793

10

Review of clinical studies of beta-blocking agents.

Zimmerman TJ. Zimmerman TJ. Surv Ophthalmol. 1989 Apr;33 Suppl:461-2; discussion 471-2. doi: 10.1016/0039-6257(89)90090-8. Surv Ophthalmol. 1989. PMID: 2568698 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results